基于网络的方法揭示了BRCA亚型中的关键基因和三阴性乳腺癌中的化疗反应
Piyush Agrawal1, Navami Jain2, Vishaka Gopalan1
1Cancer Data Science Lab, National Cancer Institute, NIH, Bethesda, MD, USA.
bioRxiv : the preprint server for biology
|July 10, 2023
概括
通过PathExt网络分析,识别了驱动乳腺癌亚型和治疗耐药性的关键基因. 这种方法完善了对转录异质性的理解,并揭示了三阴性乳腺癌 (TNBC) 的潜在治疗点.
科学领域:
- 基因组学就是基因组学.
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- 乳腺癌呈现出显著的转录异质性,使治疗反应预测和结果预后复杂化.
- 将三阴性乳腺癌 (TNBC) 亚型转化为临床实践是具有挑战性的,因为缺乏明显的转录特征.
- 疾病的全球转录性变化通常是由几个关键的介导基因驱动的.
研究的目的:
- 应用基于网络的PathExt方法来识别BRCA亚型中的关键调解基因.
- 调查这些已识别的基因的功能相关性和临床适用性.
- 发现TNBC耐药性的潜在治疗点.
主要方法:
- 应用了PathExt基于网络的方法对1059个BRCA瘤和112个健康对照在4个亚型.
- 利用差异表达分析和基因验证的基准比较.
- 分析了单细胞转录组和TNBC化疗反应数据集.
主要成果:
- PathExt识别了每种BRCA亚型特有的频繁,关键的介导基因,比传统方法显示出更大的一致性.
- 这些基因更好地回顾了与BRCA相关的基因,并在癌症细胞系中表现出更高的依赖性得分.
- 在瘤微环境细胞类型中观察到亚型特异性基因分布,并确定了与TNBC化疗耐药性相关的关键基因/过程.
结论:
- "PathExt"改进了对乳腺癌中基因表达异质性的理解.
- 该研究确定了TNBC亚型和相关药物耐药性的潜在媒介.
- 基于已识别的关键基因,针对TNBC提出了新的治疗标.
更多相关视频
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
12.3K
06:52Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
6.6K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
